Corpus ID: 2101891

[Effects of feixianping on serum interleukin-6 and oxygen partial pressure in pulmonary fibrosis rats].

@article{Wang2005EffectsOF,
  title={[Effects of feixianping on serum interleukin-6 and oxygen partial pressure in pulmonary fibrosis rats].},
  author={Shu-Chen Wang and Yan-ping Zhang and Mao-rong Fan and Qing Miao and Wei Wang and Wen-jiang Zhang and Yuan-Yuan Zhang and Jia-yang Lin},
  journal={Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine},
  year={2005},
  volume={25 2},
  pages={
          147-9
        }
}
  • Shu-Chen Wang, Yan-ping Zhang, +5 authors Jia-yang Lin
  • Published 2005
  • Medicine
  • Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine
OBJECTIVE To study the effects of feixianping (FXP) in improving hypoxemia and on serum interleukin-6 (IL-6) in experimental rats with pulmonary fibrosis (PF). METHODS Two hundred and forty healthy male SD rats were randomly divided into 5 groups, 48 in each group, i.e. the normal control group (A), the model group (B), the prednisone group (C) and the two FXP groups of high (21.6 mg x kg(-1)) and low (10.8 mg x kg(-1)) dosage (D and E). PF model rats were established by intratracheal… Expand
3 Citations
Oxidative damage to lung tissue and peripheral blood in endotracheal PM2.5-treated rats.
TLDR
The activity of GSH-Px and the concentration of MDA are valuable biomarkers of oxidative lung tissue damage induced by PM2.5 and the DNA migration length (microm) and rate of tail are simple and valuable biomarker of DNA damage in lung tissues and peripheral blood. Expand
INVITED REVIEW SERIES: PULMONARY FIBROSIS
TLDR
This review provides a summary of important arguments PRO and CON using anti-inflammatory and anti-oxidant therapy for patients with IPF in form of a debate with a concluding statement of both positions at the end. Expand
How useful is traditional herbal medicine for pulmonary fibrosis?
TLDR
There is considerable experimental support from preclinical studies for some of these herbal medicines, but the translation into clinical practice appears difficult, and the clinical trials evaluating their anti‐fibrotic potential are not fulfilling the standards expected from ‘Western’ medicines. Expand